|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mouse Protein Wnt-5a (aa 62-380) |
| Wnt-5a Swiss Prot# | | P22725 |
| Wnt-5a Protein names | | Protein Wnt-5a |
| Wnt-5a Gene names | | Wnt5a (Wnt-5a) |
| Organism | | Mus musculus (Mouse) |
| Wnt-5a Entry name | | WNT5A_MOUSE |
| Wnt-5a Codon optimized cDNA(gene) Clone |
| Wnt-5a Cat # | | RPM0405 |
| Tag | | Wnt-5a contains A 6x histidine tag |
| Wnt-5a Formulation | | Liquid |
| Wnt-5a Storage | | Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Wnt-5a Applications | | Applications: 1. Codon-optimized cDNA(gene) sequence designed for protein production in both E.coli and Mammalian cell. The cDNA(gene) has been cloned into E.coli expression vector with 6x Histidine tag.2. May be used as RNAi assistance to restore the loss-of-function. |
| Recombinant Wnt-5a Protein |
| Wnt-5a Cat # | | PM0405 |
| Wnt-5a Source | | recombinant |
| Wnt-5a Applications | | Western Blot, SDS-Page or may be used for other applications determined by user |
| Wnt-5a Purity | | >90%, as determined by SDS-PAGE under reducing conditions |
| Wnt-5a Activity | | N/A |
| Tag | | Wnt-5a Contains A 6x histidine tag |
| Wnt-5a Formulation | | Liquid |
| Wnt-5a Storage | | ;. Storage at -20℃ to −80℃ Upon receipt. Avoid repeated freeze-thaw cycles. |
| Place Order for Recombinant Wnt-5a Products | | For pricing and availability Click Here >>> |
| Wnt-5a family | | Wnt family |
| Wnt-5a Subcellular locations | | Secreted > extracellular space > extracellular matrix. |
| Wnt-5a FUNCTION According to UniProtKB Swiss Prot | | FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Can activate or inhibit canonical Wnt signaling, depending on receptor context. In the presence of FZD4, activates beta-catenin signaling. In the presence of ROR2, inhibits the canonical Wnt pathway by promoting beta-catenin degradation through a GSK3-independent pathway which involves down-regulation of beta-catenin-induced reporter gene expression. Suppression of the canonical pathway allows chondrogenesis to occur and inhibits tumor formation. Stimulates cell migration. Decreases proliferation, migration, invasiveness and clonogenicity of carcinoma cells and may act as a tumor suppressor. Mediates motility of melanoma cells. Required during embryogenesis for extension of the primary anterior-posterior axis and for outgrowth of limbs and the genital tubercle. Inhibits type II collagen expression in chondrocytes. |
| Wnt-5a Sequence | | DDBJ | EMBL | GenBank |
| Wnt-5a 3D structure | | ModBase |
| Wnt-5a interaction | | STRING |
| Wnt-5a Proteomic | | PRIDE |
| Wnt-5a Genome annotation | | Ensembl | GeneID | KEGG | UCSC |
| Wnt-5a Organism specific | | CTD | MGI |
| Wnt-5a Phylogenomics | | eggNOG | GeneTree | HOGENOM | HOVERGEN |
| | InParanoid | OrthoDB | PhylomeDB | OMA |
| Wnt-5a Gene expression | | Bgee | ArrayExpress | Genevestigator |
| Wnt-5a Family and domain | | InterPro | PROSITE | ProtoNet |
| FOR in vitro RESEARCH USE ONLY |